Post-approval studies (Phase 4)Study completedNCT00233337
What this trial is testing
Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers
Who this might be right for
Acute Uncomplicated P. Falciparum Malaria
Novartis Pharmaceuticals